CGEMBiotechnology / Biotechnology
Cullinan Therapeutics Inc
30-Day Price
Key Metrics
Latest Close
$12.74
Market Cap
$792M
Shares Outstanding
60,530,000
P/B Ratio
1.5
ROE
-2835.00%
ROA
-2692.00%
Operating Margin
-35876.00%
Net Margin
-34620.00%
Debt / Equity
0
Current Ratio
10.25
Want the full picture?
Sign up free for full analysis, strategy backtesting with credibility scoring, portfolio management, and more.
Start Free